COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI was delisted on the 3rd of September, 2025.
13 hedge funds and large institutions have $126K invested in COSCIENS Biopharma Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
8% more funds holding
Funds holding: 12 → 13 (+1)
0.03% more ownership
Funds ownership: 0.18% → 0.21% (+0.03%)
4% less capital invested
Capital invested by funds: $132K → $126K (-$5.33K)
93% less call options, than puts
Call options by funds: $174K | Put options by funds: $2.49M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
+$16.4K |
| 2 |
JP Morgan Chase
New York
|
+$2.79K |
| 3 |
Morgan Stanley
New York
|
+$2.08K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.3K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$326 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$904 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $45.8K | +$2.08K | +140 | +4% |
|
|
2
Group One Trading
Chicago,
Illinois
| $42.5K | +$16.4K | +1,103 | +50% |
|
|
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $14.7K | -$904 | -61 | -5% |
|
|
EDRH
4
Edmond de Rothschild Holding
Chambesy,
Switzerland
| $12.7K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $2K | +$193 | +13 | +11% |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$326 | +22 | +18% |
|
|
7
JP Morgan Chase
New York
| $2K | +$2.79K | +188 | New |
|
8
National Bank of Canada
Montreal,
Quebec, Canada
| $1.43K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $1.12K | +$1.3K | +88 | New |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $627 | – | – | – |
|
|
TC
12
Truvestments Capital
Sarasota,
Florida
| $280 | +$326 | +22 | New |
|
|
FWM
13
Focused Wealth Management
Newburgh,
New York
| $191 | – | – | – |
|
|
IGWM
14
ICA Group Wealth Management
Denver,
Colorado
| $3 | – | – | – |
|
|
15
Bank of America
Charlotte,
North Carolina
| – | -$1K | -50 | Closed |
|
CSCI Hedge Fund Activity: Q4 2022 in Review
13 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q4 2022, worth a combined $126K — down 4% from $132K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CSCI positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Group One Trading, adding an estimated $16.4K. The largest seller was Bank of America, exiting entirely with an estimated $1K sold.
- 13 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q4 2022, up from 12 in Q3 2022.
- Funds reported $126K of COSCIENS Biopharma Inc. Common Stock stock for Q4 2022, down 4% quarter-over-quarter.
- 3 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q4 2022 and 2 closed out, a net change of +1 holder.
- The largest COSCIENS Biopharma Inc. Common Stock buyer in Q4 2022 was Group One Trading, an estimated $16.4K added.
- The largest COSCIENS Biopharma Inc. Common Stock seller in Q4 2022 was Bank of America, an estimated $1K sold.
Based on aggregated 13F filings for Q4 2022.